Dr. Filipe Pereira is an Associate Professor at the Lund Stem Cell Center at Lund University. The Pereira lab studies how hematopoietic cell fate is specified, maintained, and eventually modified or reversed. Inspired by the fields of stem cell biology, immunology, and cancer, they use an interdisciplinary approach to mechanistically understand hematopoietic ... Show More
Nov 4
Ep. 118: “Memory B Cell Responses” Featuring Dr. Camila Coelho
Dr. Camila Coelho is a Principal Investigator at the Icahn School of Medicine at Mount Sinai, where her lab studies emerging pathogens. She talks about her lab's work on mpox and other viruses, her approach to mentorship, and how her MBA education helps her in science.
1h 12m
Oct 21
Ep. 117: “The Pathogenesis of Viruses and Cancer” Featuring Dr. Matteo Iannacone
Professor Matteo Iannacone is Director of the Division of Immunology, Transplantation and Infectious Diseases, Professor of Pathology, and Head of the Dynamics of Immune Responses laboratory at Vita-Salute San Raffaele University. His work centers on understanding the generation ... Show More
1h 13m
Oct 2024
Epigenetic Mechanisms of Mammalian Germ Cell Development (Mitinori Saitou)
In this episode of the Epigenetics Podcast, we talked with Mitinori Saitou from Kyoto University about his work on germ cell development, focusing on proteins like BLIMP1 and PRDM14, reprogramming iPSCs, and his vision to address infertility and genetic disorders through epigenet ... Show More
39m 49s
Jan 2025
The Interplay of Nutrition, Metabolic Pathways, and Epigenetic Regulation (Ferdinand von Meyenn)
In this episode of the Epigenetics Podcast, we talked with Ferdinand von Meyenn from ETH Zürich about his work on the interplay of nutrition, metabolic pathways, and epigenetic regulation. To start Dr. Meyenn recounts his pivotal research on DNA methylation in naive embryonic ste ... Show More
48m 5s
Nov 2024
CAR T Cells and T-Cell Therapies for Cancer
<p>CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins JAMA Deputy Editor Mary McGrae McDermott ... Show More
18m 22s
May 2024
Mini Episode: Enhance Stem Cell Activation Through Hyperbarics - Dr. Allen Meglin : 1163
<p>We're previewing the 10th annual Biohacking Conference in Dallas, Texas, (May 30 - June 1) on <em>The Human Upgrade</em>! </p><p>Dr. Allen Meglin and Oxy Health are at the forefront of hyperbaric medicine, a field revolutionizing the way we enhance healing and cellular he ... Show More
13m 31s
Sep 24
Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain
In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell lymphomas. Dr. David Russler-Germain, a lymphoma clinician from Siteman Cancer Centre at Washington U ... Show More
53m 8s
Feb 2025
Leading Stem Cell Expert: Stem Cells 101 - The Future of Medicine w/ Robert Hariri | EP #147
In this episode, Bob and Peter discuss Stem Cells 101, why it’s not available in America, and the importance of stem cell treatment for humanity.
Recorded on Nov 21st, 2024
Views are my own thoughts; not Financial, Medical, or Legal Advice.
Dr. Robert Hariri is the Chairman, F ... Show More
1h 18m